This publication has not received compensated product samples for testing, has not interviewed Trimi or Arora Health personnel, has not been granted access to internal product specifications beyond what is publicly published, and has not conducted independent laboratory or clinical testing of any compounded medication
Results Median BAC decreased from baseline 123 g/dl to 95.5, 88, 83, 96, and 86 g/dl at 12, 24, 48, 96, and 192 weeks, respectively (all P 1500 mg/day) achieve more rapid BAC normalization and should be considered for patients with significant hyperammonemia
Lower-dose treatment might one day suit certain patients, but she said, "Researchers need strong clinical trials first." She outlined what would have to come together: studies testing lower doses directly rather than in theory, proof that the results hold up over years without significant weight re-gain, a clearer picture of who benefits most, consistent manufacturing standards, and regulatory review of the evidence
This dual action of stimulating insulin and suppressing glucagon helps lower blood sugar more effectively